about
Diagnostic evaluation of assays for detection of antibodies against porcine epidemic diarrhea virus (PEDV) in pigs exposed to different PEDV strains.Porcine epidemic diarrhea virus RNA present in commercial spray-dried porcine plasma is not infectious to naïve pigsFirst report of hepatitis E virus circulation in domestic pigs in NigeriaMutant USA strain of porcine circovirus type 2 (mPCV2) exhibits similar virulence to the classical PCV2a and PCV2b strains in caesarean-derived, colostrum-deprived pigs.Development and application of an ELISA for the detection of porcine deltacoronavirus IgG antibodies.Evaluation of porcine epidemic diarrhea virus transmission and the immune response in growing pigsComparison of commercial real-time reverse transcription-PCR assays for reliable, early, and rapid detection of heterologous strains of porcine reproductive and respiratory syndrome virus in experimentally infected or noninfected boars by use of difEvaluation of serological cross-reactivity and cross-neutralization between the United States porcine epidemic diarrhea virus prototype and S-INDEL-variant strainsIncreased frequency of porcine epidemic diarrhea virus shedding and lesions in suckling pigs compared to nursery pigs and protective immunity in nursery pigs after homologous re-challengeComparison of real-time reverse transcriptase PCR assays for detection of swine hepatitis E virus in fecal samples.Subclinical avian hepatitis E virus infection in layer flocks in the United States.Identification of recently described porcine parvoviruses in archived North American samples from 1996 and association with porcine circovirus associated disease.First identification of porcine parvovirus 6 in Poland.Detection of immunoglobulin (Ig) A antibodies against porcine epidemic diarrhea virus (PEDV) in fecal and serum samples.Circulation of Porcine Parvovirus Types 1 through 6 in Serum Samples Obtained from Six Commercial Polish Pig Farms.Preliminary evidence of age-dependent clinical signs associated with porcine circovirus 2b in experimentally infected CH3/Rockefeller mice.A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.First Genome Sequences of Porcine Parvovirus 5 Strains Identified in Polish PigsAvian Hepatitis E Virus Infection in Organic Layers.The spray-drying process is sufficient to inactivate infectious porcine epidemic diarrhea virus in plasma.Detection of antibodies against porcine epidemic diarrhea virus in serum and colostrum by indirect ELISA.Identification and characterization of avian hepatitis E virus in 2013 outbreaks of hepatitis-splenomegaly syndrome in two US layer operations.Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.Development and validation of a 4-plex antibody assay for simultaneous detection of IgG antibodies against Torque teno sus virus 1 (TTSuV1), TTSuV2, and porcine reproductive and respiratory syndrome virus types 1 and 2.Comparison of commercial enzyme-linked immunosorbent assays and fluorescent microbead immunoassays for detection of antibodies against porcine reproductive and respiratory syndrome virus in boars.A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain.High prevalence and genetic diversity of porcine bocaviruses in pigs in the USA, and identification of multiple novel porcine bocaviruses.Association of concurrent porcine circovirus (PCV) 2a and 2b infection with PCV associated disease in vaccinated pigs.Concurrent porcine circovirus type 2a (PCV2a) or PCV2b infection increases the rate of amino acid mutations of porcine reproductive and respiratory syndrome virus (PRRSV) during serial passages in pigs.Using oral fluids samples for indirect influenza A virus surveillance in farmed UK pigs.Identification and characterization of novel porcine astroviruses (PAstVs) with high prevalence and frequent co-infection of individual pigs with multiple PAstV types.Emergence of a novel mutant PCV2b variant associated with clinical PCVAD in two vaccinated pig farms in the U.S. concurrently infected with PPV2.Evaluation of the efficacy of a commercial inactivated genogroup 2b-based porcine epidemic diarrhea virus (PEDV) vaccine and experimental live genogroup 1b exposure against 2b challenge.Development of a fluorescent microbead-based immunoassay for the detection of hepatitis E virus IgG antibodies in pigs and comparison to an enzyme-linked immunoassay.Validation of an immunoperoxidase monolayer assay for total anti-Vaccinia virus antibody titration.Lack of antibody protection against Porcine circovirus 2 and Porcine parvovirus in naturally infected dams and their offspring.Characterization of porcine parvovirus type 2 (PPV2) which is highly prevalent in the USA.Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model.Distribution of antibodies against porcine circovirus type-2 (PCV2) in single site and multi-site farrow-to-finish farms in Brazil.
P50
Q30396178-80F60054-4847-4B7A-9D41-CBC50D0F9E42Q34035113-F5C33DFA-CF5D-4F88-8A1C-4C8567F18D47Q34281534-ACC12B51-7695-49CF-816C-8A5C95554C19Q34366429-744CC8D5-37EB-4B08-8A70-81B5EBEDA086Q35447489-1F3D247F-A611-48E7-9E4E-A17DF74327ADQ35568850-FB4BC96F-9F79-435B-93D4-72B6C505373CQ36559084-4BF3D81D-93BE-4E9E-A401-601CA40A1D4AQ36765494-7D4FBE1F-A835-4E33-95C6-D97150B4B570Q37428407-C90C45C8-57C4-4A9E-815F-34C058C5977FQ37713502-CAB7B8FA-DA92-48F4-BF42-DC3CDD4BF8F1Q38383587-79D6D83E-AA0A-463C-926F-1804AD26A0F7Q38390686-3CF88523-C599-45EB-AEF5-0ACDEF53BBD8Q38824835-70418C35-9AF6-48F3-A105-AFE459C3C8DFQ38940819-096CEA93-882F-42EB-91AB-8FEAE7D5363BQ39157091-90201D84-FB22-4885-8F0F-7721DBE03A3AQ40199427-DAB8F296-66F0-42F9-9790-B222A0BB4026Q40423071-36CC54B1-9EAA-424C-A549-03DD0A15E80AQ40522324-AABAA27B-8E64-4CD0-B3AE-FF2122202CD0Q40597325-736EB3AA-E3F8-4DAA-A6DD-1E50BB273269Q40946979-63151A3D-C77B-414F-AB1D-C44176B2A12DQ41716746-243E703C-AE05-4289-A3C0-0040FE49F658Q42199249-60C70A64-DAC2-4387-AF29-73F1290FDB0FQ42206761-E755E203-BF60-4ACA-9ED7-0BDA8F9339A8Q42210470-7710620B-6ED2-42D3-B5C2-F026EBA7BFEFQ42223035-BE6BE30E-FE4E-4A4A-A826-22BD166EA8BEQ42235881-AF5E6D73-F84B-4C3C-A3B0-EF1A75F916DFQ42253611-225A46A7-6EEB-4765-A6F9-639C98E74F24Q42255015-D0CE87AE-5C6F-4FAC-9973-6BC5C1323D16Q42256198-14AEBCB7-C9B8-4123-B8B9-09F428F1C3AFQ42269656-2AC3A430-4BDA-42E5-AFF7-A70D6A3C1C6FQ42682719-4936F729-28CD-4341-9870-82D8F9B87A95Q44549310-8AD1C19E-B27B-4C4B-9323-0C125BD593BCQ44613940-9203A93B-BB14-4C63-B996-B27103B506DAQ45325624-B163CCBF-5E76-4B35-965F-30981B871500Q45350720-53F3020B-99CF-4383-BB40-21BCD4FCB27BQ45359271-F7CF821B-A535-453E-B650-707712301204Q46351623-8B5EBFDD-9937-41E9-8FAF-34085559DC0DQ46433218-7AB4FA7D-7744-459B-9D03-8B73B85C2FC9Q47547891-D02C606D-E9DD-4ECD-8AD0-25BED8777415Q47729949-D9581398-8B66-466A-952E-74B96086D593
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Priscilla F. Gerber
@ast
Priscilla F. Gerber
@en
Priscilla F. Gerber
@es
Priscilla F. Gerber
@nl
Priscilla F. Gerber
@sl
type
label
Priscilla F. Gerber
@ast
Priscilla F. Gerber
@en
Priscilla F. Gerber
@es
Priscilla F. Gerber
@nl
Priscilla F. Gerber
@sl
prefLabel
Priscilla F. Gerber
@ast
Priscilla F. Gerber
@en
Priscilla F. Gerber
@es
Priscilla F. Gerber
@nl
Priscilla F. Gerber
@sl
P1053
K-4771-2012
P106
P1153
35388126300
P21
P31
P3829
P496
0000-0002-8343-8299